A global leader in serving libraries of all types, ProQuest LLC (“ProQuest”) supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience. More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others.
Newsline Regimen Treat complete heart risk improves had never had a heart attack. Five years of treatment tailored to such knee OA factors as age, family history, high BP, high C-reactive protein levels, STRENGTH-TRAINING regi- presence of diabetes, and smok- mens, self-management programs, ing status showed more beneﬁt or a combination of the two are per person treated and prevented equally beneﬁcial for physically substantially more heart attacks, inactive, middle-aged people with strokes, and cardiovascular deaths symptomatic osteoarthritis (OA) than the currently recommended of the knee, according to a recent treat-to-target approaches. For study (Arthritis Care Res. 2010; example, the tailored treatment 62:45-53). approach was predicted to save Relatively few studies have 520,000 more quality-adjusted examined the potential beneﬁt life-years than an intensive NCEP of using both approaches simul- TAILORING treatment to a Fixating on III treat-to-target approach per taneously. The fact that the indi- person’s overall, individual heart only LDL ﬁve years of treatment. vidual treatments work as well as attack risk was more effective in cholesterol “The beneﬁts of tailored treat- the combined regimen offers a preventing heart attack, stroke, and often leads ment result from targeting high- relatively simple way to manage cardiovascular death than current to treating risk patients better and basing OA in its early stages. strategies to drive down choles- the wrong intensiﬁcation decisions on a per- The two-year trial involved 201 terol to a target based on National people. son’s estimated treatment ben- adul
Pages to are hidden for
"Regimen improves knee OA"Please download to view full document